Unknown

Dataset Information

0

Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis.

ABSTRACT:

SUBMITTER: Mullen M 

PROVIDER: S-EPMC8782585 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis.
| S-EPMC8918972 | biostudies-literature
Unknown miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer.
| S-EPMC6192997 | biostudies-literature
Unknown SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer.
| S-EPMC6110877 | biostudies-literature
Unknown CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1.
| S-EPMC6949091 | biostudies-literature
Unknown Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration.
| S-EPMC8344951 | biostudies-literature
Unknown Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells.
| S-EPMC10377353 | biostudies-literature
Unknown OTUB2 promotes proliferation and metastasis of triple-negative breast cancer by deubiquitinating TRAF6.
| S-EPMC12034018 | biostudies-literature
Unknown PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer.
| S-EPMC10770055 | biostudies-literature
Unknown Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.
| S-EPMC4228255 | biostudies-literature
Unknown Metformin Inhibits Cell Motility and Proliferation of Triple-Negative Breast Cancer Cells by Blocking HMGB1/RAGE Signaling.
| S-EPMC12025684 | biostudies-literature